Hainan Shuangcheng Pharmaceuticals (SHE:002693) is seeking compensation worth almost 52 million yuan in its lawsuit against Zhongrong International Trust over a business trust dispute, according to a Shenzhen bourse filing on Wednesday.
The Chinese pharmaceutical company purchased financial products totaling 50 million yuan from Zhongrong International Trust in 2022 and 2023. The products have been defaulted, but only the partial interest was paid to the company.
The amount the company seeks includes 21.1 million yuan in trust proceeds from the B859 Trust Unit and 30.9 million yuan from the A36 Trust Unit.
The company's shares dropped over 4% at the close of Wednesday's trade.
Comments